Rhumbline Advisers Sera Prognostics, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 32,633 shares of SERA stock, worth $213,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,633
Previous 32,166
1.45%
Holding current value
$213,746
Previous $190,000
33.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SERA
# of Institutions
69Shares Held
20.4MCall Options Held
120KPut Options Held
0-
Baker Bros. Advisors LP New York, NY5.43MShares$35.6 Million0.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$19.9 Million0.33% of portfolio
-
Interwest Venture Management CO2.42MShares$15.8 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$10.8 Million1.88% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$9.23 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $194M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...